Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in Southern California


    loading  Checking for direct PDF access through Ovid

Abstract

Despite its importance in drug metabolism and disease susceptibility, CYP2D6 activity and genetic polymorphism have rarely been investigated in African-American populations. In order to bridge this gap, we examined the genotype and phenotype of the enzyme in 154 African-American (AA) and 143 Caucasian (C) normal volunteers. AAs are significantly more likely to possess * 17 and * 5, but less likely to have * 4. Overall, the two groups were similar in their CYP2D6 activity as measured with dextromethorphan as the probe (metabolic ratio 2.21 ± 0.78 for AAs; 2.11 ± 0.86 for Cs; t = 1.02, NS). Two of four AAs and six of seven Cs were classified as poor metabolizers and have two nonfunctioning alleles. CYP2D6 activity is determined by * 17, * 4, * 5 and age in AAs (r2 = 0.33, f = 18.8, P< 0.001) and by * 4 and * XN in Cs (r2 = 0.14, f = 10.8, P< 0.001). These results support previous findings demonstrating the importance of * 17 in determining CYP2D6 activity in AAs.

    loading  Loading Related Articles